A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known human enzyme, which may have implications for treating respiratory diseases such as asthma.
Enzymes made from artificial molecules which do not occur anywhere in nature have been shown to trigger chemical reactions in the lab, challenging existing views about the conditions that are needed to enable life to happen.
Elizabeth Blackburn, an alumna of Darwin College and a recipient of an Honorary Doctorate of Science from the University earlier this year, has been awarded the Nobel Prize in medicine.
Scientists have discovered a completely new route by which leukaemia develops, according to research published in Nature this weekend.
© 2024 University of Cambridge